Russell Investments Group Ltd. Has $91.42 Million Stock Holdings in Healthpeak Properties, Inc. $DOC

Russell Investments Group Ltd. decreased its position in Healthpeak Properties, Inc. (NYSE:DOC) by 3.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,271,632 shares of the real estate investment trust’s stock after selling 138,382 shares during the period. Russell Investments Group Ltd. owned 0.62% of Healthpeak Properties worth $91,418,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in DOC. Clearstead Trust LLC lifted its position in Healthpeak Properties by 66.7% during the 2nd quarter. Clearstead Trust LLC now owns 1,357 shares of the real estate investment trust’s stock valued at $29,000 after purchasing an additional 543 shares during the period. Advocate Investing Services LLC acquired a new stake in shares of Healthpeak Properties during the 4th quarter worth approximately $26,000. WPG Advisers LLC grew its position in shares of Healthpeak Properties by 270.2% during the 4th quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock worth $26,000 after buying an additional 1,197 shares during the period. CYBER HORNET ETFs LLC bought a new stake in shares of Healthpeak Properties during the second quarter worth approximately $33,000. Finally, Clearstead Advisors LLC raised its stake in shares of Healthpeak Properties by 166.3% during the fourth quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock worth $31,000 after buying an additional 1,216 shares during the last quarter. Institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

DOC stock opened at $20.78 on Friday. The business’s 50-day moving average price is $21.33 and its two-hundred day moving average price is $18.90. The company has a current ratio of 3.02, a quick ratio of 3.02 and a debt-to-equity ratio of 1.06. The firm has a market cap of $14.33 billion, a PE ratio of 59.38, a P/E/G ratio of 3.20 and a beta of 1.01. Healthpeak Properties, Inc. has a 1-year low of $15.70 and a 1-year high of $22.95.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.05. Healthpeak Properties had a return on equity of 2.79% and a net margin of 8.24%.The firm had revenue of $771.58 million during the quarter, compared to analysts’ expectations of $725.64 million. During the same period in the previous year, the firm earned $0.46 earnings per share. The company’s revenue was up 11.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. As a group, research analysts forecast that Healthpeak Properties, Inc. will post 1.77 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be given a $0.1017 dividend. The ex-dividend date is Monday, September 14th. This represents a c) annualized dividend and a dividend yield of 5.9%. Healthpeak Properties’s payout ratio is currently 348.57%.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on DOC. Scotiabank increased their price objective on shares of Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a report on Wednesday, May 27th. Mizuho lifted their target price on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, July 6th. Raymond James Financial assumed coverage on shares of Healthpeak Properties in a research report on Wednesday, June 17th. They set a “market perform” rating for the company. Wall Street Zen raised Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Sunday, May 10th. Finally, Citigroup raised their price target on Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Tuesday. Four equities research analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $21.44.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.